MedTrace Logo

The Effect of Turmeric on New Onset Primary Dysmenorrhea

NCT04183556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-04-24

No results posted yet for this study

Summary

The study was planned as 150 patients. Patients who met early-onset dysmenorrhea criteria and who met the inclusion criteria; 150 patients were divided into 2 equal groups, and NSAID during the menstrual cycle, nsai + turmeric 1 gr oral powder form treatment was planned to be started in the other group. The pain frequency and severity before and after treatment were evaluated by visual analog scale and the two groups were compared.

Conditions

  • Primary Dysmenorrhea

Interventions

DRUG

Naproxen

use of naproxen twice a day orally in mens time

DIETARY_SUPPLEMENT

Turmeric

Use of turmeric orally (1 gram powder formula) in mens time

Sponsors & Collaborators

  • Batman Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • erhan okuyan · Batman Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2020-04-23
Completion
2020-04-23

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04183556 on ClinicalTrials.gov